FDA.reportPublic FDA data

elbasvir 50 MG / grazoprevir 100 MG Oral Tablet

RxCUI
1734636
RxNorm name
elbasvir 50 MG / grazoprevir 100 MG Oral Tablet
Display name
elbasvir 50 MG / grazoprevir 100 MG Oral Tablet
Full name
elbasvir 50 MG / grazoprevir 100 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:48

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ZEPATIERELBASVIR AND GRAZOPREVIRMerck Sharp & Dohme LLC164dc02a-9180-426a-b8b5-04ab39d2bbd42026-03-13Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1734636

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
164dc02a-9180-426a-b8b5-04ab39d2bbd4elbasvir 50 MG / grazoprevir 100 MG Oral TabletPSN22These highlights do not include all the information needed to use ZEPATIER safely and effectively. See full prescribing information for ZEPATIER. ZEPATIER ® (elbasvir and grazoprevir) tablets, for oral use Initial U.S. Approval: 201620260313
164dc02a-9180-426a-b8b5-04ab39d2bbd4elbasvir 50 MG / grazoprevir 100 MG Oral TabletSCD22These highlights do not include all the information needed to use ZEPATIER safely and effectively. See full prescribing information for ZEPATIER. ZEPATIER ® (elbasvir and grazoprevir) tablets, for oral use Initial U.S. Approval: 201620260313